⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL175725 | 0.73 | MGLL (0.42) | — | |
| SCHEMBL515246 | 0.71 | — | — | |
| SCHEMBL16129944 | 0.69 | — | — | |
| SCHEMBL2571475 | 0.69 | — | — | |
| SCHEMBL2922210 | 0.69 | — | — | |
| SCHEMBL18282001 | 0.69 | — | — | |
| SCHEMBL8556424 | 0.67 | GAA (0.32) | — | |
| SCHEMBL9463988 | 0.66 | MGLL (0.37) | — | |
| SCHEMBL9809715 | 0.66 | GAA (0.31) | — | |
| SCHEMBL5053834 | 0.66 | GAA (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190023743-A1 | METHODS AND COMPOSITIONS FOR MODULATING DRUG-POLYMER ARCHITECTURE, PHARMACOKINETICS AND BIODISTRIBUTION | DUKE UNIVERSITY | 2019-01-24 | — | — | US | claimed |
| US-20140024600-A1 | METHODS AND COMPOSITIONS FOR MODULATING DRUG-POLYMER ARCHITECTURE, PHARMACOKINETICS AND BIODISTRIBUTION | DUKE UNIVERSITY (US) | 2014-01-23 | — | — | US | claimed |
| US-20110207673-A1 | METHODS AND COMPOSITIONS FOR MODULATING DRUG-POLYMER ARCHITECTURE, PHARMACOKINETICS AND BIODISTRIBUTION | DUKE UNIVERSITY | 2011-08-25 | — | — | US | claimed |
| WO-2009067584-A1 | METHODS AND COMPOSITIONS FOR MODULATING DRUG-POLYMER ARCHITECTURE, PHARMACOKINETICS AND BIODISTRIBUTION | DUKE UNIVERSITY (US) | 2009-05-28 | — | — | WO | claimed |
| US-20250302981-A1 | NOVEL USE OF ANTICANCER AGENT PRODRUG CONJUGATE | UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION (KR) | 2025-10-02 | — | — | US | disclosed |
| WO-2025098478-A1 | WHOLE-PROCESS TARGETING POLYPEPTIDE, PHARMACEUTICAL COMPLEX THEREOF, DRUG DELIVERY SYSTEM AND USE THEREOF | 复旦大学 | 2025-05-15 | — | — | WO | disclosed |
| WO-2025053315-A1 | METHOD FOR RECOVERING AND REMOVING PALLADIUM IN PREPARATION OF ANTICANCER AGENT PRODRUG CONJUGATE | 파로스젠 주식회사 | 2025-03-13 | — | — | WO | disclosed |
| US-11622990-B2 | VAP polypeptide and use thereof in preparation of drug for targeted diagnosis and treatment of tumor | FUDAN UNIVERSITY (CN) | 2023-04-11 | — | — | US | disclosed |
| US-11572373-B2 | Maytansinoid-based drug delivery systems | LADRX CORPORATION (US) | 2023-02-07 | — | — | US | disclosed |
| CN-109265512-B | Preparation method of protein conjugate based on pyridine dicarbaldehyde | 清华大学 | 2021-06-11 | — | — | CN | disclosed |
| US-20200385403-A1 | MAYTANSINOID-BASED DRUG DELIVERY SYSTEMS | LADRX CORPORATION | 2020-12-10 | — | — | US | disclosed |
| US-20190314446-A1 | VAP POLYPEPTIDE AND USE THEREOF IN PREPARATION OF DRUG FOR TARGETED DIAGNOSIS AND TREATMENT OF TUMOR | FUDAN UNIVERSITY (CN) | 2019-10-17 | — | — | US | disclosed |
| WO-2005115477-A2 | NON-NATURAL RIBONUCLEASE CONJUGATES AS CYTOTOXIC AGENTS | QUINTESSENCE BIOSCIENCES, INC. (US) | 2005-12-08 | — | — | WO | disclosed |
| US-20050261232-A1 | Non-natural ribonuclease conjugates as cytotoxic agents | QUINTESSENCE BIOSCIENCES, INC. (US) | 2005-11-24 | — | — | US | disclosed |
| US-20050002942-A1 | Minimized toxicity; eliminating pathogenic cell populations; synthesis; claimed intermediates | ENDOCYTE, INC. | 2005-01-06 | — | — | US | disclosed |
| CN-1509166-A | Liposome composition for improved intracellular delivery of therapeutic agent | — | 2004-06-30 | — | — | CN | disclosed |
| EP-1019722-B1 | POLYMERIC FLUOROPHORES ENHANCED BY MOIETIES PROVIDING A HYDROPHOBIC AND CONFORMATIONALLY RESTRICTIVE MICROENVIRONMENT | ABBOTT LAB (US) | 2003-04-09 | — | — | EP | disclosed |
| EP-1019722-A1 | POLYMERIC FLUOROPHORES ENHANCED BY MOIETIES PROVIDING A HYDROPHOBIC AND CONFORMATIONALLY RESTRICTIVE MICROENVIRONMENT | Abbott Laboratories (US) | 2000-07-19 | — | — | EP | disclosed |
| US-5994143-A | FLUORESCENT CONJUGATES SUITABLE FOR USE IN FLOW CYTOMETRY AND OTHER BIOLOGICAL APPLICATIONS; THE FLUORESCENT CONJUGATES COMPRISE AN ANTIBODY HAVING A POLYMERIC DYE BOUND THERETO | ABBOTT LABORATORIES (US) | 1999-11-30 | — | — | US | disclosed |
| WO-1997028447-A1 | POLYMERIC FLUOROPHORES ENHANCED BY MOIETIES PROVIDING A HYDROPHOBIC AND CONFORMATIONALLY RESTRICTIVE MICROENVIRONMENT | ABBOTT LABORATORIES (US) | 1997-08-07 | — | — | WO | disclosed |